Using SlimTrack® to help postmenopausal women manage weight and health
Effects of the SlimTrack® Platform on Diet Adherence, Body Weight Variation, Anthropometric Variables and Arterial Stiffness in Postmenopausal Women: Pilot Study
This study tests if the SlimTrack digital tool can help postmenopausal women lose weight and improve their health by encouraging better eating habits and physical activity.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 64 (estimated) |
| Ages | 45 Years to 60 Years |
| Sex | Female |
| Sponsor | Instituto de Cardiologia do Rio Grande do Sul Academic / other |
| Locations | 1 site (Porto Alegre, Rio Grande do Sul) |
| Trial ID | NCT06497946 on ClinicalTrials.gov |
What this trial studies
This study evaluates the SlimTrack Platform, an interactive digital tool designed to assist postmenopausal women in managing obesity and weight loss through diet adherence and physical activity. Over a 21-day period, participants will engage in activities that address emotional and psychological aspects of weight management while tracking their anthropometric measurements and arterial stiffness. The study aims to assess the effectiveness of this platform in promoting healthier lifestyles among women who are overweight or obese. Participants will be randomly assigned to use the platform and will report their progress throughout the intervention.
Who should consider this trial
Good fit: Ideal candidates for this study are postmenopausal women who are overweight or obese and lead a sedentary lifestyle.
Not a fit: Patients currently using hormone therapy or psychiatric medications, or those who have had recent surgeries or cardiovascular events, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve weight management and overall health in postmenopausal women.
How similar studies have performed: Other studies have shown promise in using digital platforms for weight management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria * Menopause * Overweight * Obesity * Sedentary lifestyle Exclusion Criteria: * Use of hormone therapy * Use of pharmacologial pshychiatric medication * Recent surgery (six months) * Recent (six months) cardiardiovascular events (myocardial infarction, stroke) * Adherence to diet in the last six months * Attending to psychoterapeutic proccess
Where this trial is running
Porto Alegre, Rio Grande do Sul
- Instituto de Cardiologia do Rio Grande do Sul — Porto Alegre, Rio Grande do Sul, Brazil (Recruiting)
Study contacts
- Study coordinator: Mariana Ms Ávila, Graduated
- Email: nutmarianaavila@gmail.com
- Phone: 51996540423
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.